Key result
Cardiovascular risk scores are excellent for risk stratification, but their actual use in clinical environments lags behind the rate of new risk score creation.
Highlights the need for future research to focus on the effective and efficient clinical implementation of existing cardiovascular risk scores rather than creating new ones.
Cardiovascular disease remains the primary cause of mortality and morbidity in the developed world. Risk scores can provide clinical risk stratification and many exist for use in cardiovascular disease prevention and treatment. Cardiovascular risk scores predict mortality, coronary heart disease and other vascular disease using risk predictors such as patient age, sex, BMI, smoking history, cholesterol level, blood pressure, glucose level or diabetes diagnosis, family history of cardiovascular disease and creatinine. While the risk scores in existence are excellent for risk stratification, actual use in a clinical environment is lagging behind the rate of new risk score creation. Future research should focus on how to utilize risk scores most effectively and efficiently in clinical practice.
No takes yet. Share an insight, caveat, or question.
Horne et al. (2012) conducted a review in Cardiovascular disease. Cardiovascular risk scores was evaluated. Cardiovascular risk scores are excellent for risk stratification, but their actual use in clinical environments lags behind the rate of new risk score creation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: